
Aryzta AG
SIX:ARYN

US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
58.08
87
|
Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

Intrinsic Value
The intrinsic value of one
ARYN
stock under the Base Case scenario is
92
CHF.
Compared to the current market price of 82.1 CHF,
Aryzta AG
is
Undervalued by 11%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Aryzta AG
Historical valuation for ARYN cannot be conducted due to limitations such as insufficient data or other constraints.
JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
|
CH |
![]() |
Nestle SA
SIX:NESN
|
|
US |
![]() |
Mondelez International Inc
NASDAQ:MDLZ
|
|
FR |
![]() |
Danone SA
PAR:BN
|
|
ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
|
CH |
![]() |
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
|
US |
![]() |
Hershey Co
NYSE:HSY
|
|
CN |
![]() |
Muyuan Foods Co Ltd
SZSE:002714
|
|
US |
![]() |
Kraft Heinz Co
NASDAQ:KHC
|
|
CN |
![]() |
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:


Revenue & Expenses Breakdown
Aryzta AG
Balance Sheet Decomposition
Aryzta AG
Current Assets | 362.4m |
Cash & Short-Term Investments | 77.1m |
Receivables | 142.5m |
Other Current Assets | 142.8m |
Non-Current Assets | 1.5B |
PP&E | 871.3m |
Intangibles | 632.8m |
Other Non-Current Assets | 44.5m |
Current Liabilities | 569.3m |
Accounts Payable | 423.4m |
Accrued Liabilities | 24.6m |
Other Current Liabilities | 121.3m |
Non-Current Liabilities | 889.6m |
Long-Term Debt | 784.6m |
Other Non-Current Liabilities | 105m |
Free Cash Flow Analysis
Aryzta AG
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Aryzta AG
Revenue
|
2.2B
EUR
|
Cost of Revenue
|
-1.4B
EUR
|
Gross Profit
|
750.6m
EUR
|
Operating Expenses
|
-560.6m
EUR
|
Operating Income
|
190m
EUR
|
Other Expenses
|
-89.9m
EUR
|
Net Income
|
100.1m
EUR
|
ARYN Profitability Score
Profitability Due Diligence
Aryzta AG's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Score
Aryzta AG's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
ARYN Solvency Score
Solvency Due Diligence
Aryzta AG's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Score
Aryzta AG's solvency score is 25/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ARYN Price Targets Summary
Aryzta AG
According to Wall Street analysts, the average 1-year price target for
ARYN
is 93.33 CHF
with a low forecast of 80.8 CHF and a high forecast of 100.8 CHF.
Dividends
Current shareholder yield for ARYN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ARYN
stock under the Base Case scenario is
92
CHF.
Compared to the current market price of 82.1 CHF,
Aryzta AG
is
Undervalued by 11%.